Tags

Tags

Displaying 51 - 60 of 83
Cover image of Developing the cancer-fighting drugs of tomorrow

Developing the cancer-fighting drugs of tomorrow

24 Oct 2019
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the diversity of treatment have improved assuring now a 90% five-year survival rate, metastatic breast…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the diversity of treatment have improved…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the diversity of treatment have…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools…
Cover image of Versatile nanoparticles take aim at complex bone diseases

Versatile nanoparticles take aim at complex bone diseases

24 May 2019
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions of people worldwide suffering from bone cancer, bacterial bone…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone…
Cover image of 2018 Research highlights

2018 Research highlights

12 Mar 2019
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights from the last year:
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights from the last year:
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights…
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights from the last year:
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we…
Cover image of Spotting the killjoy cell

Spotting the killjoy cell

11 Feb 2019
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In such a densely populated environment, the chances of detecting a single tumour cell circulating in…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In such a densely populated environment…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In such a densely populated…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of…
Cover image of A new weapon against pancreatic cancer on the way ?

A new weapon against pancreatic cancer on the way ?

24 Jan 2019
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death by cancer in Europe. It…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the…
Cover image of When scientific curiosity sparks innovation

When scientific curiosity sparks innovation

05 Dec 2018
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy events like these may seem almost science fictional at moments and it can be…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy events like…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official…
Cover image of Medical imaging: Can we predict how cancer patients will respond to nanotherapies?

Medical imaging: Can we predict how cancer patients will respond to nanotherapies?

01 Oct 2018
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan Lammers has devised imaging which differentiates between those likely to benefit and those unlikely…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan Lammers has devised imaging which…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan Lammers has devised…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour…
Cover image of Organoids in the fight against cancer

Organoids in the fight against cancer

29 Jun 2018
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate…
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional…
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that…
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex…

Understanding acidification to fight infection

28 May 2018
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell Host Microbe, they outline the significance of a single protein, SLC4A7, in phagocytosis, the body's…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell Host Microbe, they outline the…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell Host Microbe, they outline…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper…
Cover image of Building a multi-level simulation of organogenesis

Building a multi-level simulation of organogenesis

20 Jul 2017
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart, the brain, a limb. But what are the mechanisms behind these molecular, cellular and tissue…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart, the brain, a limb. But what are…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart,…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart, the brain, a limb. But…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large…